0000899243-21-046120.txt : 20211124 0000899243-21-046120.hdr.sgml : 20211124 20211124210925 ACCESSION NUMBER: 0000899243-21-046120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211111 FILED AS OF DATE: 20211124 DATE AS OF CHANGE: 20211124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaFrance Norman D. CENTRAL INDEX KEY: 0001397768 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34375 FILM NUMBER: 211448928 MAIL ADDRESS: STREET 1: MOLECULAR INSIGHT PHARMCEUTICALS, INC. STREET 2: 160 SECOND STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PLUS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001095981 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330827593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4200 MARATHON BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 BUSINESS PHONE: 737.255.7194 MAIL ADDRESS: STREET 1: 4200 MARATHON BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 FORMER COMPANY: FORMER CONFORMED NAME: CYTORI THERAPEUTICS, INC. DATE OF NAME CHANGE: 20050712 FORMER COMPANY: FORMER CONFORMED NAME: MACROPORE INC DATE OF NAME CHANGE: 20010320 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-11 0 0001095981 PLUS THERAPEUTICS, INC. PSTV 0001397768 LaFrance Norman D. C/O PLUS THERAPEUTICS INC. 4200 MARATHON BOULEVARD, SUITE 200 AUSTIN TX 78756 0 1 0 0 CHIEF MEDICAL OFFICER Stock Option (right to buy shares of common stock) 120000.00 2021-11-01 4 A 0 120000 0.00 A 2031-11-11 Common Stock 120000 120000 D 25% of the options will vest on November 11, 2022 with the remaining options vesting over the subsequent three years in equal monthly installments. Andrew Sims, as attorney-in-fact 2021-11-24